US equities
|
MU
$896.07
▼-0.98%
SPCX
$147.79
▼-0.11%
NVDA
$216.47
▼-0.29%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
MU
$896.07
▼-0.98%
SPCX
$147.79
▼-0.11%
NVDA
$216.47
▼-0.29%
AAPL
$339.50
▼-1.00%
TSLA
$373.71
▲+1.54%
META
$694.25
▼-1.59%
AMZN
$262.63
▲+0.07%
SNDK
$1,365.38
▼-0.42%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Perception Neurosciences
Recent news which mentions Perception Neurosciences
Atai Advances R-Ketamine Through Phase 1 Bridging Study, Update And Near-Term Expectations
April 14, 2023
Tickers
ATAI
Tags
Benzinga
Perception Neurosciences
News
From
Benzinga